Details for 2018837151
Up to date per 03.04.2026
Actions
Details for 2018837151
Granted/Registered
European Patent
03.06.2020 A
05.06.2024 B1
28.07.2017
US
201762538536 P
19.09.2017
US
201762560615 P
27.04.2018
US
201862664048 P
C07D 471/04 20060101AFI20201102BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka 540-8645JP
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
MASSE, Craig E.122 Hamilton Street Cambridge Massachusetts 02139US
GREENWOOD, Jeremy Robert338 Prospect Place Apt. 3E Brooklyn New York 11238US
MONDAL, Sayan405 Main Street Apt. 15A New York New York 10044US
COWEN, Scott D.c/o Nimbus Lakshmi Inc. 130 Prospect Street Suite 301 Cambridge Massachusetts 02139US
MCLEAN, Thomas H.c/o Nimbus Lakshmi Inc. 130 Prospect Street Suite 301 Cambridge Massachusetts 02139US
Information about Fees